I agree that this site is using cookies. You can find further informations here.
X
Grunnet, Morten
157  results:
Search for persons X
?
1

A phase 1 trial of AP30663, a KCa2 channel inhibitor in dev..:

Yfanti, Christina ; Vestbjerg, Birgitte ; van't Westende, Juliette...
British Journal of Clinical Pharmacology.  90 (2024)  4 - p. 1027-1035 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Inhibition of the KCa2 potassium channel in atrial fibrilla..:

Holst, Anders G. ; Tomcsányi, János ; Vestbjerg, Birgitte...
Nature Medicine.  30 (2023)  1 - p. 106-111 , 2023
Link: https://doi.org/10.1038/..
 
?
3

Inhibition of the K(Ca)2 potassium channel in atrial fibril..:

Holst, Anders G ; Tomcsányi, János ; Vestbjerg, Birgitte...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803288/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Beta2‐agonist increases skeletal muscle interleukin 6 produ..:

Hostrup, Morten ; Knudsen, Jakob Grunnet ; Kristensen, Caroline Maag...
Scandinavian Journal of Medicine & Science in Sports.  32 (2022)  7 - p. 1099-1108 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Inhibition of KCa2 Channels Decreased the Risk of Ventricul..:

Diness, Jonas Goldin ; Abildgaard, Lea ; Bomholtz, Sofia Hammami...
Frontiers in Pharmacology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
6

Inhibition of KCa2 and Kv11.1 Channels in Pigs With Left Ve..:

Citerni, Carlotta ; Kirchhoff, Jeppe ; Olsen, Lisbeth Høier...
Frontiers in Pharmacology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
7

The Small Conductance Calcium-Activated Potassium Channel I..:

Burashnikov, Alexander ; Barajas-Martinez, Hector ; Hu, Dan...
Journal of Cardiovascular Pharmacology.  76 (2020)  2 - p. 164-172 , 2020
Link: https://doi.org/10.1097/..
 
?
8

The KCa2 Channel Inhibitor AP30663 Selectively Increases At..:

Diness, Jonas Goldin ; Kirchhoff, Jeppe Egedal ; Speerschneider, Tobias...
Frontiers in Pharmacology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
9

Characterization of Atrial and Ventricular Structural Remod..:

Citerni, Carlotta ; Kirchhoff, Jeppe ; Olsen, Lisbeth Høier...
Frontiers in Veterinary Science.  7 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
10

In vitro and in vivo characterization of Lu AA41178: A nove..:

Grupe, Morten ; Bentzen, Bo Hjorth ; Benned-Jensen, Tau...
European Journal of Pharmacology.  887 (2020)  - p. 173440 , 2020
Link: https://doi.org/10.1016/..
 
?
11

First Clinical Study with AP30663 ‐ a KCa2 Channel Inhibito..:

Gal, Pim ; Klaassen, Erica S. ; Bergmann, Kirsten R....
Clinical and Translational Science.  13 (2020)  6 - p. 1336-1344 , 2020
Link: https://doi.org/10.1111/..
 
?
12

Mechanisms of Action of the KCa2-Negative Modulator AP30663..:

Bentzen, Bo Hjorth ; Bomholtz, Sofia Hammami ; Simó-Vicens, Rafel...
Frontiers in Pharmacology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
13

Data_Sheet_1_Characterization of Atrial and Ventricular Str..:

Carlotta Citerni ; Jeppe Kirchhoff ; Lisbeth Høier Olsen...
doi:10.3389/fvets.2020.00179.s001.  , 2020
Link: https://doi.org/10.3389/..
 
?
14

DataSheet_1_Inhibition of KCa2 and Kv11.1 Channels in Pigs ..:

Carlotta Citerni ; Jeppe Kirchhoff ; Lisbeth Høier Olsen...
doi:10.3389/fphar.2020.00556.s001.  , 2020
Link: https://doi.org/10.3389/..
 
?
15

Mechanisms of Action of the KCa2-Negative Modulator AP30663..:

Bo Hjorth Bentzen ; Sofia Hammami Bomholtz ; Rafel Simó-Vicens...
https://www.frontiersin.org/article/10.3389/fphar.2020.00610/full.  , 2020
Link: https://doi.org/10.3389/..
 
1-15